Agios Pharmaceuticals Q1 2024 GAAP EPS $(1.45) Beats $(1.64) Estimate, Sales $8.189M Miss $8.370M Estimate

Author: Benzinga Newsdesk | May 02, 2024 07:06am
Agios Pharmaceuticals (NASDAQ:AGIO) reported quarterly losses of $(1.45) per share which beat the analyst consensus estimate of $(1.64) by 11.59 percent. This is a 1.36 percent increase over losses of $(1.47) per share from the same period last year. The company reported quarterly sales of $8.189 million which missed the analyst consensus estimate of $8.370 million by 2.17 percent. This is a 46.00 percent increase over sales of $5.609 million the same period last year.

Posted In: AGIO